Lmr Partners LLP Tyme Technologies, Inc. Transaction History

Lmr Partners LLP

  • $10.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$0.99 - $1.38 $25,916 - $36,125
-26,178 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.14 - $1.87 $29,842 - $48,952
26,178 New
26,178 $33,000
Q4 2019

Feb 14, 2020
SELL
$1.0 - $1.49 $14,239 - $21,216
-14,239 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$0.96 - $1.89 $13,669 - $26,911
14,239 New
14,239 $17,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email